|
SON expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1219999999933E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.040900E-04 |
| Normal-vs-Stage2 |
2.161000E-03 |
| Normal-vs-Stage3 |
1.45220000002944E-06 |
| Normal-vs-Stage4 |
1.22810000002804E-06 |
| Stage1-vs-Stage2 |
5.570600E-01 |
| Stage1-vs-Stage3 |
5.778300E-02 |
| Stage1-vs-Stage4 |
6.719500E-02 |
| Stage2-vs-Stage3 |
4.795200E-01 |
| Stage2-vs-Stage4 |
3.627600E-01 |
| Stage3-vs-Stage4 |
7.190200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78303999999185E-05 |
| Normal-vs-AfricanAmerican |
2.447800E-01 |
| Normal-vs-Asian |
5.361200E-03 |
| Caucasian-vs-AfricanAmerican |
6.862500E-02 |
| Caucasian-vs-Asian |
4.353800E-01 |
| AfricanAmerican-vs-Asian |
2.865400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50249999999463E-05 |
| Normal-vs-Female |
1.50406999999131E-05 |
| Male-vs-Female |
4.506800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.181910E-03 |
| Normal-vs-Age(41-60Yrs) |
2.21129999999903E-06 |
| Normal-vs-Age(61-80Yrs) |
4.23120000003774E-06 |
| Normal-vs-Age(81-100Yrs) |
3.259800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.151570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.496400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.399200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.632200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.519800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.104600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.220220E-02 |
| Classical-VS-Follicular |
3.755200E-03 |
| Classical-VS-Other |
1.927420E-01 |
| Classical-VS-Normal |
1.461890E-03 |
| Tall-VS-Follicular |
7.872600E-01 |
| Tall-VS-Other |
9.896200E-01 |
| Tall-VS-Normal |
1.57452999999252E-05 |
| Follicular-VS-Other |
8.949800E-01 |
| Follicular-VS-Normal |
1.25620000002158E-06 |
| Other-VS-Normal |
8.701000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.23490000015059E-07 |
| Normal-vs-N1 |
1.80139999994555E-06 |
| N0-vs-N1 |
4.283600E-01 |
|
|
